Cytocell Ltd. today announced the availability of a new molecular cytogenetic test designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung ...

OXFORD, England, September 22, 2025--(BUSINESS WIRE)--OGT, a leading global provider of genomic diagnostic and research solutions, announced today that the U.S. Food and Drug Administration (FDA) has ...

The CytoCell KMT2A Breakapart FISH Probe Kit PDx is approved as a companion diagnostic for revumenib in KMT2A translocated acute leukemia. Revumenib showed a 21.2% complete remission rate in ...

The new cost-effective and quality-assured probes are optimised for use on common sample types and are sold as pre-mixed, easy-to-use formulations to minimise experimental errors. The importance of ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched a new version of its Cytocell ® fluorescence in situ hybridization (FISH) probes website - designed to provide a wealth of ...

Oxford Gene Technology (OGT), The Molecular Genetics Company,has expanded its range of Cytocell Aquarius ® fluorescence in situ hybridisation (FISH) probes for pathology. OGT has introduced three new ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, based in Oxfordshire, United Kingdom, acquired Cytocell, based in Cambridge, United Kingdom, in March. OGT announced that it will directly ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched a new version of its Cytocell® fluorescence in situ hybridisation (FISH) probes website - designed to provide a wealth of ...

Cytocell Ltd. announced the availability of a new range of in vitro diagnostic tests to aid in detecting patients with Chronic Lymphocytic Leukaemia (CLL), a cancer ...

Oxford Gene Technology (OGT) said it acquired Cytocell, in a deal that expands OGT’s genomic medicine offerings into fluorescence in situ hybridization (FISH) diagnostic products, and immediately ...

CAMBRIDGE, England, Nov. 26, 2013 /CNW/ - Cytocell Ltd. announced the availability of a new range of in vitro diagnostic tests to aid in detecting patients with Chronic Lymphocytic Leukaemia (CLL), a ...